Health Dictionary Find a Doctor

Choledocholithiasis

Template:DiseaseDisorder infobox

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Overview

Choledocholithiasis is the presence of gallstones in the common bile duct. This condition causes jaundice and liver cell damage, and is a medical emergency, requiring the endoscopic retrograde cholangiopancreatography (ERCP) procedure or surgical treatment. A tendency for this disease can be inherited.

Historical Perspective

There is limited information about the historical perspective of choledocholithiasis

Classification

Choledocholithiasis can be classified as Primary or Secondary. Primary Choledocholithiasis is classified based on gallstones formed directly within the biliary and obstructing the common bile duct. Primary Choledocholithiasis is composed of brownstones and is less common compared to secondary choledocholithiasis. Primary choledocholithiasis often affect the biliary tree diffusely and have both intrahepatic and extrahepatic biliary stones. Intrahepatic stones may be complicated by recurrent pyogenic cholangitis.Secondary Choledocholithiasis is classified based on gallstones formed from the gallbladder and transported to block the common bile duct. This type of Choledocholithiasis is the most common type of Choledocholithiasis. The stone composition of secondary choledocholithiasis is similar to cholelithiasis with cholesterol stone as the most common type, and the cause is identical to the causes of gallstones.

Pathophysiology

It is understood that the Bile is made in the liver and stored in the gallbladder. Concentrated bile from the gallbladder can lead to the formation of gallstone. The stone passes from the gallbladder to the cystic duct, then into the common bile duct (CBD), and block the CBD. Primary Choledocholithiasis is formed from stones within the bile duct that occur due to bile stasis in the CBD, forming an intraductal stone. The cause of bile duct stasis includes bile duct dilatation with increasing age. Less commonly, bile stasis can result from complications from Mirizzi Syndrome or hepatolithiasis (gallstone in the biliary duct of the liver). The obstructed flow of the bile duct leads to obstructive jaundice and possibly hepatitis. The stagnant Bile can lead to infection and inflammation of the bile duct, causing bactibilia and ascending cholangitis. If the blockage is at the common bile duct after the pancreatic duct, join the CBD, it can become inflamed, with autoactivation of pancreatic enzymes leading to gallstone pancreatitis

Causes

While stones can frequently pass through the common bile duct into the duodenum, some stones may be too large to pass through the CBD and will cause an obstruction. Choledocholithiasis causes include primary and secondary causes. Primary causes are rare, and they are usually brown pigment stones formed in the bile duct. Recurrent pyogenic cholangitis (RCC), also known as Oriental Cholangiohepatitis hepatolithiasis, is an intrahepatic brown pigment stone exclusive to individuals who live or lived in southeast Asia. It is caused by a bacterial in the bile duct, undernutrition, and parasitic infection (e.g., Clonorchis Sinensis, Opisthorchis viverrini) leading to chronic bacterial cholangitis with hepatolithiasis|primary hepatolithiasis. Secondary causes occur in greater than 85% of people in a developed country, and about 10% presents symptomatically after Cholecystectomy. Secondary causes are caused by stones from the gallbladder, with cholesterol stones being the most common.

Differentiating Choledocholithiasis overview from Other Diseases

Choledocholithiasis must be differentiated from other diseases that cause jaundice, right upper quadrant pain, fever, nausea and vomiting, such as Cholecystitis, Perforated peptic ulcer, Acute peptic ulcer exacerbation, Amoebic liver abscess, Acute amoebic liver colitis, Acute pancreatitis, Acute intestinal obstruction, Renal colic, Acute retrocolic appendicitis.

Epidemiology and Demographics

The incidence and prevalence of choledocholithiasis are unknown, but Choledocholithiasis has been found in 4.6% to 18.8% of patients undergoing cholecystectomy.

Risk Factors

Common risk factors in the development of Choledocholithiasis are the same as gallstones which include being a female, age 40 or older, obesity, pregnancy, high-fat diet, rapid weight loss, and liver disease. Risk Factors can be classified as either modifiable or non-modifiable.

Screening

There is insufficient evidence to recommend routine screening for Choledocholithiasis.

Natural History, Complications, and Prognosis

The choledocholithiasis symptoms typically develop as a result of stone from the gallbladder blocking the common bile duct or from stone formation within the bile duct, usually asymptomatic. According to Wenckert et al., approximately 25–50% of patients with retained bile duct stones developed severe complications, mainly jaundice or pancreatitis.

Diagnosis

History and Symptoms

Symptoms usually do not occur unless the stone blocks the common bile duct. Symptoms that may occur include, Abdominal pain in the right upper or middle upper abdomen that may come and go, sharp, cramping, or dull, Spread to the back or below the right shoulder blade, Get worse after eating fatty or greasy foods, Occurs within minutes of a meal along with Fever, Loss of appetite and Jaundice (yellowing of skin and whites of eyes).

Physical Examination

Patients with choledocholithiasis usually asymptomatic. Physical examination of patients with choledocholithiasis is usually non-remarkable. The physical finding is associated with the complication of the disease.

Laboratory Findings

The laboratory data may be normal in as many as a thirds of patients with choledocholithiasis, and further evaluation of the Common bile duct is recommended by imaging studies to clarify the diagnosis.

Imaging Findings

Ultrasound is helpful first in establishing a diagnosis of Choledocholithiasis and the most common screening tool used for choledocholithiasis. Findings on ultrasound suggestive of Choledocholithiasis include dilated bile duct, visualization of stone(s), and gallstones should increase suspicion.

Treatment

Medical Therapy

There is no medical therapy for choledocholithiasis; the mainstay of therapy for symptomatic choledocholithiasis is surgery and reducing risk factors. Medical therapy used to treat gallstone can be recommended to choledocholithiasis secondary to gallstone.

Surgery

The goal of treatment is to relieve the blockage. Surgery is the mainstay of treatment for symptomatic choledocholithiasis. The procedure is Biliary endoscopic sphincterotomy, an essential procedure of endoscopic retrograde cholangiopancreatography (ERCP). The procedure involves cutting the sphincter between the common bile duct and the pancreatic duct using a flexible catheter and wire to remove the stone.

Prevention

Effective measures for the primary prevention include diet with sufficient fat and protein, maintaining a low body weight, and avoiding prolonged fasting.

References

Template:WS Template:WH

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Overview

There is limited information about the historical perspective of choledocholithiasis

Historical Perspective

There is limited information about the historical perspective of choledocholithiasis

References

Template:WS Template:WH

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Overview

Choledocholithiasis can be classified as Primary or Secondary.

Classification

Choledocholithiasis can be classified as Primary or Secondary

  • Primary Choledocholithiasis is classified based on gallstones formed directly within the biliary and obstructing the common bile duct. Primary Choledocholithiasis is composed of brownstones and is less common compared to secondary choledocholithiasis. Primary choledocholithiasis often affect the biliary tree diffusely and have both intrahepatic and extrahepatic biliary stones. Intrahepatic stones may be complicated by recurrent pyogenic cholangitis.[1]
  • Secondary Choledocholithiasis is classified based on gallstones formed from the gall bladder and transported to block the common bile duct. This type of Choledocholithiasis is the most common type of Choledocholithiasis. The stone composition of secondary choledocholithiasis is similar to cholelithiasis with cholesterol stone as the most common type, and the cause is identical to the causes of gallstones. About 4.6% to 18.8% of patients undergoing cholecystectomy is found to have choledocholithiasis.[2]

References

  1. Guzmán-Calderón E (2017). Steinstrasse” in the Biliary Tract”. Eurasian J Med. 49 (2): 159–160. doi:10.5152/eurasianjmed.2017.17098. PMC 5469848. PMID 28638265.
  2. Molvar C, Glaenzer B (2016). “Choledocholithiasis: Evaluation, Treatment, and Outcomes”. Semin Intervent Radiol. 33 (4): 268–276. doi:10.1055/s-0036-1592329. PMC 5088099. PMID 27904245.

Template:WS Template:WH

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Overview

It is thought that Choledocholithiasis is the result of gallstone produced either in the gall bladder or bile duct obstructing the common bile duct.

Pathophysiology

It is understood that the Bile is made in the liver and stored in the gallbladder. Concentrated bile from the gallbladder can lead to the formation of gallstone. The stone passes from the gallbladder to the cystic duct, then into the common bile duct (CBD), and block the CBD. [1]

Primary Choledocholithiasis is formed from stones within the bile duct that occur due to bile stasis in the CBD, forming an intraductal stone. The cause of bile duct stasis includes bile duct dilatation with increasing age. Less commonly, bile stasis can result from complications from Mirizzi Syndrome or hepatolithiasis (gallstone in the biliary duct of the liver). The obstructed flow of the bile duct leads to obstructive jaundice and possibly hepatitis. The stagnant Bile can lead to infection and inflammation of the bile duct, causing bactibilia and ascending cholangitis. If the blockage is at the common bile duct after the pancreatic duct, join the CBD, it can become inflamed, with autoactivation of pancreatic enzymes leading to gallstone pancreatitis. Choledocholithiasis can also be secondary to cholelithiasis and choledochoduodenal-fistula stricture. choledochoduodenal-fistula is an abnormal opening in choledochus and the duodenum and a rare complication of chronic duodenal ulcer with cholelithiasis. The stone formed in the gallstone and transported to the gallbladder usually pure choleterol stone, but can be pigment stones or mixed composition. The cholesterol stone is formed from supersaturation of cholesterol when there is not enough bile to saturate the choleterol in solution or impaired motility of the gallbladder. Pigment stone are formed from red blood cells breakdown.[2] [3] [4] [5]

References

Template:WS Template:WH

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Overview

Choledocholithiasis causes include primary and secondary causes.

Causes

While stones can frequently pass through the common bile duct into the duodenum, some stones may be too large to passthrough the CBD and will cause an obstruction. Choledocholithiasis causes include primary and secondary causes.

  • Primary causes are rare, and they are usually brown pigment stones formed in the bile duct. Recurrent pyogenic cholangitis (RCC), also known as Oriental Cholangiohepatitis hepatolithiasis, is an intrahepatic brown pigment stone exclusive to individuals who live or lived in southeast Asia. It is caused by a bacterial in the bile duct, undernutrition, and parasitic infection (e.g., Clonorchis Sinensis, Opisthorchis viverrini) leading to chronic bacterial cholangitis with hepatolithiasis|primary hepatolithiasis.
  • Secondary causes occur in greater than 85% of people in a developed country, and about 10% presents symptomatically after Cholecystectomy. Secondary causes are caused by stones from the gallbladder, with cholesterol stones being the most common.

Other causes include residual stones that develop in the ducts greater than three years after surgery.[1]

References

Template:WH Template:WS

Differentiating Choledocholithiasis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Overview

Choledocholithiasis must be differentiated from other diseases that cause jaundice, right upper quadrant pain, fever, nausea and vomiting, such as Cholecystitis, Perforated peptic ulcer, Acute peptic ulcer exacerbation, Amoebic liver abscess, Acute amoebic liver colitis, Acute pancreatitis, Acute intestinal obstruction, Renal colic, Acute retrocolic appendicitis.

Differentiating Choledocholithiasis from other Diseases

Choledocholithiasis must be differentiated from

Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram, US = Ultrasound

Classification of pain in the abdomen based on etiology Disease Clinical manifestations Diagnosis Comments
Symptoms Signs
Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Constipation Diarrhea Weight loss GI bleeding Hypo-

tension

Guarding Rebound Tenderness Bowel sounds Lab Findings Imaging
Abdominal causes Inflammatory causes Pancreato-biliary disorders Acute cholecystitis RUQ + + + Hypoactive Ultrasound shows:
  • Gallstone
  • Inflammation
Acute suppurative cholangitis RUQ + + + + + + + N
  • Abnormal LFT
  • WBC >10,000
  • Ultrasound shows biliary dilatation/stents/tumor
  • Septic shock occurs with features of SIRS
Acute cholangitis RUQ + + N
  • Ultrasound shows biliary dilatation/stents/tumor
  • Biliary drainage (ERCP) + IV antibiotics
Cholelithiasis RUQ/Epigastric ± ± ± Normal to hyperactive for dislodged stone
  • Fatty food intolerance
Primary biliary cirrhosis RUQ/Epigastric + N
  • Increased AMA level, abnormal LFTs
  • ERCP
  • Pruritis
Primary sclerosing cholangitis RUQ + + N ERCP and MRCP shows
  • Multiple segmental strictures
  • Mural irregularities
  • Biliary dilatation and diverticula
  • Distortion of biliary tree
  • The risk of cholangiocarcinoma in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population.
Hepatic causes Viral hepatitis RUQ + + + Positive in Hep A and E + Positive in fulminant hepatitis Positive in acute + N
  • Abnormal LFTs
  • Viral serology
  • US
  • Hep A and E have fecal-oral route of transmission
  • Hep B and C transmits via blood transfusion and sexual contact.
Liver abscess RUQ + + + + ± + + + ± Normal or hypoactive
  • US
  • CT
Hepatocellular carcinoma/Metastasis RUQ + + +
  • Normal
  • Hyperactive if obstruction present
  • US
  • CT
  • Liver biopsy

Other symptoms:

Disease Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Constipation Diarrhea Weight loss GI bleeding Hypo-

tension

Guarding Rebound Tenderness Bowel sounds Lab Findings Imaging Comments
Budd-Chiari syndrome RUQ ± ± Positive in liver failure leading to varices N
Findings on CT scan suggestive of Budd-Chiari syndrome include:
Ascitic fluid examination shows:
Hemochromatosis RUQ Positive in cirrhotic patients N
  • >60% TS
  • >240 μg/L SF
  • Raised LFT
    Hyperglycemia
  • Ultrasound shows evidence of cirrhosis
Extra intestinal findings:
  • Hyperpigmentation
  • Diabetes mellitus
  • Arthralgia
  • Impotence in males
  • Cardiomyopathy
  • Atherosclerosis
  • Hypopituitarism
  • Hypothyroidism
  • Extrahepatic cancer
  • Prone to specific infections
Cirrhosis RUQ + + + + N US
  • Stigmata of liver disease
  • Cruveilhier- Baumgarten murmur
Disease Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Constipation Diarrhea Weight loss GI bleeding Hypo-

tension

Guarding Rebound Tenderness Bowel sounds Lab Findings Imaging Comments
Intestinal causes Acute appendicitis Starts in epigastrium, migrates to RLQ + Positive in pyogenic appendicitis + ± Positive in perforated appendicitis + + Hypoactive
  • Ct scan
  • Ultrasound
  • Positive Rovsing sign
  • Positive Obturator sign
  • Positive Iliopsoas sign
Irritable bowel syndrome Diffuse ± ± + N Normal Normal Symptomatic treatment
Hollow Viscous Obstruction Biliary colic RUQ + + N
  • Ultrasound
Extra-abdominal causes Pulmonary causes Pulmonary embolism RUQ/LUQ ± ± N
  • ABGs
  • D-dimer
  • Dyspnea
  • Tachycardia
  • Pleuretic chest pain
Pneumonia RUQ/LUQ + + + ± + Normal or hypoactive
  • ABGs
  • Leukocytosis
  • Pancytopenia
  • CXR
  • CT chest
  • Bronchoscopy
  • Shortness of breath
  • Cough

References

  1. “StatPearls”. 2020. PMID 28722990.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Overview

The incidence and prevalence of choledocholithiasis are unknown, but Choledocholithiasis has been found in 4.6% to 18.8% of patients undergoing cholecystectomy

Epidemiology and Demographics

References

  1. “StatPearls”. 2020. PMID 28722990.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.

Overview

Common risk factors in the development of Choledocholithiasis are the same as gallstone, which includes being a female, age 40 or older, obesity, pregnancy, high-fat diet, rapid weight loss, and liver disease.

Risk Factors

Common risk factors in the development of Choledocholithiasis are the same as gallstones which include being a female, age 40 or older, obesity, pregnancy, high-fat diet, rapid weight loss, and liver disease. Risk Factors can be classified as either modifiable or non-modifiable

  • Modifiable risk factors
    • Cholecystectomy
    • obesity
    • low-fiber, high-calorie, high-fat diet
    • pregnancy
    • prolonged fasting
    • rapid weight loss
    • lack of physical activity
  • Non-modifiable risk factors
    • Age: older adults typically have a higher risk for gallstones
    • Gender: women are more likely to have gallstones
    • Ethnicity: Asians, American Indians, and Mexican Americans are at higher risk for gallstones
    • Family history: genetics may play a role. [1].[2]


Choledocholithiasis can also occur in people who have had their gallbladder removed

References

  1. Lammert F, Gurusamy K, Ko CW, Miquel JF, Méndez-Sánchez N, Portincasa P; et al. (2016). “Gallstones”. Nat Rev Dis Primers. 2: 16024. doi:10.1038/nrdp.2016.24. PMID 27121416.
  2. https://www.healthline.com/health/choledocholithiasis#who-is-at-risk

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

Overview

There is insufficient evidence to recommend routine screening for Choledocholithiasis

Screening

There is insufficient evidence to recommend routine screening for Choledocholithiasis

References

Template:WS Template:WH

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adenike Eketunde

Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.

Overview

Natural History

The choledocholithiasis symptoms typically develop as a result of stone from the gallbladder blocking the common bile duct or from stone formation within the bile duct, usually asymptomatic. According to Wenckert et al., approximately 25–50% of patients with retained bile duct stones developed severe complications, mainly jaundice or pancreatitis. [1]

Complications

Prognosis

Prognosis is generally not associated with increase mortality. However, the prognosis from complications such as pancreatitis, cholangitis, secondary biliary cirrhosis can be fatal. Blockage and infection caused by stones in the biliary tract can be life threatening. However, with prompt diagnosis and treatment, the outcome is usually very good.

References

  1. Wenckert A, Robertson B (1966). “The natural course of gallstone disease: eleven-year review of 781 nonoperated cases”. Gastroenterology. 50 (3): 376–81. PMID 5905358.

Template:WH Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH